| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106
Alveolar macrophages are poor APCs that only minimally express B7 costimulatory molecules. Because our previous data suggest that bronchial epithelial cells constitutively secrete IL-10, and IL-10 inhibits B7 expression in vitro, we hypothesized that this IL-10 is responsible for suppressing B7 expression on macrophages that enter the airways. Furthermore, because we have shown that cystic fibrosis (CF) lungs are deficient in IL-10, we hypothesized that bronchoalveolar macrophages (BALMs) from cystic fibrosis transmembrane conductance regulator (CFTR)-/- as well as IL-10-/- mice might express increased B7. Immunofluorescence for B7 was positive on BALMs from CF patients and CFTR-/- and IL-10-/- mice, but was negative on controls. FACS showed that 63.9% of BALMs from IL-10-/- mice were B7-1 positive, as were 67.4% of BALMs from CFTR-/- mice, whereas <7% of BALMs from wild-type controls were positive. Using BALMs to costimulate splenic T cells with anti-CD3 as a mitogen showed 9202 ± 2107 cpm [3H]thymidine incorporation for BALMs from IL-10-/- mice and 4082 ± 1036 cpm for BALMs from CFTR-/- mice, but <200 cpm with BALMs from either type of +/+ mouse. Treatment of CFTR-/- mice with recombinant mouse IL-10 reduced the B7 expression and costimulatory activity of the BALMs. These data suggest that the IL-10 secreted in the healthy lung may be responsible for the absence of B7 and poor costimulatory activity of BALMs and that reductions of pulmonary IL-10 in CF may enhance B7 expression and local immune responses.
This article has been cited by other articles:
|
|
 |
|
  S. Arimilli, E. M. Palmer, and M. A. Alexander-Miller Loss of function in virus-specific lung effector T cells is independent of infection J. Leukoc. Biol., March 1, 2008; 83(3): 564 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Haase, A. Klawitter, P. Geyer, and G. B. Baretton Expression of the Immunomodulator IL-10 in Type I Pneumocytes of the Rat: Alterations of IL-10 Expression in Radiation-induced Lung Damage J. Histochem. Cytochem., November 1, 2007; 55(11): 1167 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Garantziotis, D. M. Brass, J. Savov, J. W. Hollingsworth, E. McElvania-TeKippe, K. Berman, J. K. L. Walker, and D. A. Schwartz Leukocyte-Derived IL-10 Reduces Subepithelial Fibrosis Associated with Chronically Inhaled Endotoxin Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 662 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Hallows, A. C. Fitch, C. A. Richardson, P. R. Reynolds, J. P. Clancy, P. C. Dagher, L. A. Witters, J. K. Kolls, and J. M. Pilewski Up-regulation of AMP-activated Kinase by Dysfunctional Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Airway Epithelial Cells Mitigates Excessive Inflammation J. Biol. Chem., February 17, 2006; 281(7): 4231 - 4241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bensalem, A. P. Ventura, B. Vallee, J. Lipecka, D. Tondelier, N. Davezac, A. D. Santos, M. Perretti, A. Fajac, I. Sermet-Gaudelus, et al. Down-regulation of the Anti-inflammatory Protein Annexin A1 in Cystic Fibrosis Knock-out Mice and Patients Mol. Cell. Proteomics, October 1, 2005; 4(10): 1591 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Fainaru, D. Shseyov, S. Hantisteanu, and Y. Groner Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease PNAS, July 26, 2005; 102(30): 10598 - 10603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Lee, H. L. Elmer, K. R. Ross, and T. J. Kelley Isoprenoid-Mediated Control of SMAD3 Expression in a Cultured Model of Cystic Fibrosis Epithelial Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 234 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Fulton, S. M. Reba, R. K. Pai, M. Pennini, M. Torres, C. V. Harding, and W. H. Boom Inhibition of Major Histocompatibility Complex II Expression and Antigen Processing in Murine Alveolar Macrophages by Mycobacterium bovis BCG and the 19-Kilodalton Mycobacterial Lipoprotein Infect. Immun., April 1, 2004; 72(4): 2101 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fernandez, P. Jose, M. G. Avdiushko, A. M. Kaplan, and D. A. Cohen Inhibition of IL-10 Receptor Function in Alveolar Macrophages by Toll-Like Receptor Agonists J. Immunol., February 15, 2004; 172(4): 2613 - 2620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Qureshi, A. G. Harmsen, and B. A. Garvy IL-10 Modulates Host Responses and Lung Damage Induced by Pneumocystis carinii Infection J. Immunol., January 15, 2003; 170(2): 1002 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Tabary, C. Muselet, S. Escotte, F. Antonicelli, D. Hubert, D. Dusser, and J. Jacquot Interleukin-10 Inhibits Elevated Chemokine Interleukin-8 and Regulated on Activation Normal T Cell Expressed and Secreted Production in Cystic Fibrosis Bronchial Epithelial Cells by Targeting the IkB Kinase {alpha}/{beta} Complex Am. J. Pathol., January 1, 2003; 162(1): 293 - 302. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
